Introduction
============

Drug-related attentional bias (AB), the effect for which substance-addicted patients involuntarily orient their attention toward drug-related cues, has been considered a fundamental factor in substance abuse, addiction development and maintenance ([@B59]; [@B24]; [@B20]; [@B77]). AB has been observed in various types of addictions, including alcohol ([@B84]), cigarette ([@B7]), heroin ([@B92]), and cocaine ([@B57]), even in abstinent individuals ([@B65]; [@B75]; [@B90]). For example, previous studies have shown that abstinent heroin addicts (AHAs) exhibit AB to heroin-related stimuli ([@B56]). However, few studies investigated the underlying neural correlates of AB for heroin-related stimuli in AHAs. The dot-probe task, developed by [@B55], is a widely used paradigm to investigate AB ([@B66]; [@B86]). It is based on the observation that subjects tend to respond faster to a probe stimulus that is presented in an attended rather than unattended area ([@B23]). Recently, the task has been extended to investigate AB in cigarette ([@B18]; [@B82]), alcohol ([@B41]; [@B58]; [@B8]), as well as drug dependence ([@B52]; [@B4]; [@B21]; [@B29]).

Electroencephalography directly measures neural activity, which can be used to investigate information processing and functional interactions in the human brain with millisecond resolution ([@B49]). Particularly, the high temporal resolution of event-related potentials (ERPs) allows us to examine sequential cognitive processing states involved in a task. For example, early visual components approximately 80--250 ms after the stimuli onset, P1 or N1, are typically associated with the lower-order visual processing ([@B67]), such as the identification of stimuli and their global encoding process ([@B91]), whereas late components from 250 to 500 ms, P2, N2, and P3, are thought to reflect higher-order cognitive processes ([@B60]; [@B38]; [@B35]; [@B42]), such as selective attention processing, conflict processing, stimulus categorizing, and inhibition processes ([@B53]; [@B2]). The P3 component is a positive deflection with a peak around 300 ms after stimulus onset ([@B32]), which is related to selective attention processes. Overall, ERPs permit to explore the neural basis of cognitive processes with high sensitivity and reliability, and are complementary to behavioral analyses conducted, for instance, by measuring reaction times (RTs) ([@B39]).

Previous brain imaging studies, using positron-emission tomography (PET) and functional magnetic resonance imaging (fMRI) techniques, have reported that the brain regions that are most vulnerable to heroin addiction are specific prefrontal, parietal, occipital, and temporal regions and subcortical regions ([@B40]) linked with reward, motivation/drive, memory/learning, inhibition as well as emotional control ([@B69]). AB to drug-related cues generally activates parts of the prefrontal cortex that are relevant to attentional processing ([@B31]), such as dorsolateral prefrontal cortex (dlPFC), the anterior cingulate cortex (ACC), and the inferior frontal gyrus (IFG). However, the low temporal resolution of PET and fMRI does not allow us to disentangle fast cognitive processes underlying AB. In this regard, the EEG source localization technique can be utilized to explore the underlying neural changes of drug-related AB and the associated brain regions ([@B20]; [@B36]; [@B13]).

The aim of this study is to investigate the neural abnormalities of drug-related AB in heroin dependence using a dot-probe task, combining ERP analyses, and source localizations. We hypothesize that AHAs would respond faster than healthy controls (HCs) to the dots that replace drug-related stimuli compared to neutral stimuli. Furthermore, we expect that source analysis of ERP components in AHAs would provide electrophysiological evidences for abnormalities in cognitive processing related to AB.

Materials and Methods {#s1}
=====================

Participants
------------

We enrolled 45 participants (all males) in the study, including 21 AHAs and 24 HCs. The AHAs (age: *M* = 37.33 years, *SD* = 7.18 years) were recruited from the Gansu Compulsory Isolated Detoxification Center in China, meeting the criteria of Diagnosis and Statistics of Mental Disorder 5th edition (DSM-V) for heroin dependence. The AHAs who participated in our study were abstinent from heroin and other dependent drugs for at least 1 month (abstinent period: *M* = 4.43 months, *SD* = 4.42 months). The HCs (age: *M* = 35.29 years, *SD* = 8.11 years) were recruited from the local community, and had no history of alcohol or drug abuse. These two groups showed no significant difference in the age \[*t*(43) = 0.889, *p* = 0.379\], but the educational level was significantly lower in AHAs (*M* = 2.62, *SD* = 2.75 years) compared to HCs (*M* = 6.71, *SD* = 3.7 years) \[*t*(43) = -4.16, *p* \< 0.05\]. All the subjects were right-handed, had normal or corrected-to-normal visual acuity, and no history of neurological problems. None of the subjects were taking any psychotropic, neurological, or psychiatric medications at the time of experiment. All participants gave written informed consent before participating in the study, which had been approved by the Ethics Commission of Institute of Psychology of Chinese Academy of Sciences (Approval Number: H15020).

Stimuli
-------

We selected drug-related images and neutral scenic images as stimuli to be used in the dot-probe task. We initially selected 60 images from Institute of Psychology of the Chinese Academy of Sciences, including 30 heroin-related images and 30 neutral images. The heroin-related stimuli were images of drug paraphernalia and scenes of an unidentified addict injecting drugs. All stimuli were matched for brightness, contrast, and color. The images were rated on a scale from one to nine by heroin addicts (*N* = 29) who met the addiction criteria of DSM-V and had no history of neurological problems. The 10 images with the highest scores (score: 7.91 ± 0.11) were selected as drug-related cues, and 10 images with the lowest scores (score: 1.42 ± 0.23) were selected as neutral images. Notably, the scores of the drug-related images were significantly higher than those of the neutral images \[unpaired *t*-test, *t*(18) = 79.5, *p* \< 0.005\].

Procedure
---------

The experiment was performed in a quiet, air-conditioned laboratory with dimly natural light. The participants were seated comfortably in front of a 21-inch computer screen. To reduce excessive eye movements and blinks, participants were instructed to keep fixation on the center of screen during experiment.

The dot-probe task was programmed and presented using E-Prime 2.0 (Psychology Software Tools, Inc.). The experimental paradigm was shown in **Figure [1](#F1){ref-type="fig"}**. Specifically, each trial began with a fixation cross (1 cm × 1 cm) in the center of the screen for 1000 ms. Immediately following offset of the fixation cross, a pair of images was presented for 500 ms. Each pair contained a drug-related image and a neutral image. In each pair, one of the stimuli appeared to the left of the fixation cross and one appeared to the right, with a visual angle of 10 degrees. The location of the drug-related image was randomized across trials. The images were immediately followed by the target stimulus, which was either a horizontal pair of dots or a vertical pair. Each dot had 5 mm center distance, with 1 mm radius. The target stimuli remained 200 ms. The participants were asked to judge whether the dots were oriented vertically or horizontally, and to press the response key as soon as possible. They were instructed to press the button by using the middle finger and the index finger of the right hand. If the answer was incorrect or took longer than 1000 ms, the screen showed a feedback warning ('X' or '?'), whereas no feedback was present if the response was correct and fast enough. During the intertrial interval, which lasted 1350 ms, a black screen without fixation cross was presented.

![Experimental paradigm. Each trial began with a fixation cross with 1000 ms duration. Immediately following offset of the fixation cross, a drug-related image and a neutral image were presented bilaterally for 500 ms. Next, a target stimulus, which was either a horizontal or a vertical pair of dots, was shown for 200 ms. The trial ended with a 1350 ms intertrial interval.](fnhum-11-00646-g001){#F1}

There were four kinds of target stimuli: (1) drug-related cue and target both in the left visual field, (2) drug-related cue and target both in the right visual field, (3) drug-related cue in the left, and target in the right visual field, and (4) drug-related cue in the right, and target in the left visual field. Each condition was presented 60 times, resulting in a total of 240 trials. The first two conditions, in which the drug-related cue and target are in the same side, are referred to as the congruent (CON) condition, and the other two, in which the drug-related cue and target are in the different sides, as the incongruent (INCON) condition.

Before the real experiment, the participant had one or more practice runs (20 trials each), during which EEG was not recorded, until he/she reached a response accuracy of 80%. The real experiment was composed of three runs. Each of these had 80 trials, and lasted about 6 min.

EEG Recording and Processing Procedures
---------------------------------------

EEG signals were recorded using a 64-channel electrode cap (Brain Products, Gilching, Germany) with International 10/20 montage. The scalp impedance of each sensor was kept below 10 kΩ, as suggested by the manufacturer. The EEG signals were recorded at a sampling rate of 5000 Hz with the vertex electrode as reference, and filtered in the band 0.01--100 Hz.

Signal processing and analysis of the EEG data was performed using BrainVision Analyzer 2.0 (Brain Products, Gilching, Germany). The raw EEG signals were resampled at 1000 Hz and then band-pass filtered at 1--40 Hz with a FIR filter. Independent component analysis (ICA) was used to remove the ocular and muscle artifacts ([@B14]). The cleaned EEG signals were re-referenced using the average reference.

ERP Calculation
---------------

EEG data were segmented into epochs from 100 ms before image onset to 500 ms after image onset. The pre-stimulus was used for baseline correction. In addition, the EEG data were segmented into epochs starting 700 ms before the dot stimulus onset, which is 200 ms before image onset, and ending 1000 ms after dot stimulus onset. In the latter case, epochs were baseline corrected in the time window from 700 to 500 ms before dot stimulus onset. Due to the carryover effects of image stimulus, the average voltage of 200--0 ms before dot stimulus onset biased, was thus not suitable for the baseline (Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). Trials with a feedback warning, which was present in the case of incorrect behavioral response, were excluded. The EEG epochs with absolute voltage value exceeding 100 μV were also excluded from analyses. The trials of single ERP waveforms superimposed were not less than 40 for each condition and per subject (57.43 ± 0.42 for image-locked P1, N1, P2, and N2; 114.38 ± 0.79 for target-locked P3).

Analysis of ERP Components
--------------------------

In this study, we investigated ERP components and the corresponding source-space activity to clarify the neural correlates of drug-related AB in heroin dependence. Specifically, we examined five ERP components associated with different stages of attention processing: image-elicited P1, N1, P2, and N2, and target-elicited P3 ([@B6]; [@B83]). Since the image-elicited response lasted relatively long, the early components for target-elicited response were severely distorted by the image-elicited response. Therefore, early ERP components elicited by target (dot) stimulus were not considered in this study.

We calculated image-elicited P1, N1, P2, and N2 in two conditions, referring to drug-related cue either on the left or on the right. P1 was defined as the first positive peak within a 20 ms time window around the P1 peak (the 'peak window') after picture onset for each subject. N1 was defined as the first negative peak within 50 ms around the peak identified in the time window from 170 to 220 ms. P1 and N1 were examined at the electrode O1, PO3, PO7 or O2, PO4, PO8, in the hemisphere contralateral to the drug-related cue, considering the effect of optic chiasm in the early visual response. In addition, P2 was measured by averaging activity in the time window 240--320 ms after image onset at O1, O2, Oz, PO3, PO4, PO7, and PO8 electrodes. N2 was defined as the second negative peak in the time window 250--350 ms after the image onset at FC1, FC2, FC3, FC4, FCz, C1, C2, C3, C4, and Cz electrodes. We also examined the target-related P3, the most prominent ERP component related to attentional processes ([@B88]). P3 was defined by the average activity in a 100 ms time window between 300 and 400 ms at CP1, CP2, CP3, CP4, CPz, P1, P2, P3, P4, and Pz electrodes, for congruent and incongruent conditions.

ERP Source Localization
-----------------------

To identify the brain regions involved in AB and their specific role in attentional processing, we reconstructed the ERP sources ([@B71]) and compared neuronal activity between two groups in the same condition (between-subject comparison) or between different conditions in the same group (within-subject comparison). A forward head model was built by using the boundary element method (BEM), using a MNI152 template ([@B26]; [@B70]) and standard electrode positions. Then, the activity at each brain voxel was estimated by exact low-resolution brain electromagnetic tomography (eLORETA) using the sLORETA and eLORETA software package ([@B70]; [@B71]). eLORETA has been demonstrated to have lower localization error compared to LORETA ([@B37]) and to be suitable for accurate EEG source localizations ([@B95]). The brain sources were constrained to be in the cortical gray matter, resulting in 6239 voxels at 5 mm resolution.

To enhance the spatial sensitivity of the ERP procedure, we used the following time windows on the EEG source analysis: P1 (the 20-ms peak window), N1 (170--220 ms), P2 (240--320 ms), N2 (250--350 ms), and P3 (the 100-ms peak window). Source reconstruction was performed for each experimental condition (image stimulus and target stimulus) and group (AHA and HC), respectively. To be noted, the sources were computed in the frequency range 1--40 Hz. It is important to note that, given the ill-posedness of EEG source localizations, the maps presented in this study should be considered rough estimates of the brain sources during the dot-probe task.

Statistical Analysis
--------------------

For the behavioral results, a 2 × 2 Analysis of variance (ANOVA) was performed on the RTs for correct responses, with the group (AHA vs. HC) as between-subjects factor and target-stimuli condition (congruent vs. incongruent) as within-subjects factor.

Statistical analyses of ERP components were performed with SPSS 19.0 (IBM, Armonk, NY, United States). We used an ANOVA to investigate if there were differences between AHA and HC. We performed a test of homogeneity of variances, and adjusted *F* values using Brown--Forsythe's and Welch's corrections if necessary. For repeated-measure ANOVA, the Mauchly's test was used to test for sphericity, and the Greenhouse-Geisser correction was applied if necessary.

For the image-elicited P1, N1, P2, and N2 components, we performed a 2 × 2 repeated-measure ANOVA with group (AHA vs. HC) as a between-subjects factor and position of the drug-related cues (left vs. right) as within-subjects factors. For the target-elicited P3 component, repeated measures ANOVA were performed with target-stimuli (congruent vs. incongruent) as within-subjects factor and group (AHA vs. HC) as between-subjects factor. The statistical significance was set to *p* = 0.05 with family-wise error (FWE) correction for multiple comparisons.

Group-level source images were generated by using group as between-subject factor in each condition. ANOVA was calculated to examine significance differences per time period and per condition within each group (AHA or HC) and between groups (AHA vs. HC). The statistical significance level was set to *p* = 0.05. In addition, voxel-wise *t*-tests (two-tailed) were performed to compare current density between conditions in each group and between groups.

Results
=======

The task performance, measured by accuracy rate, for AHAs (92.64 ± 4.61%) and HCs (92.82 ± 4.02%) showed no significant difference \[*t*(43) = 0.0283, *p* = 0.9776\], implying that the difference in the educational level between AHAs and HCs did not affect task performance. A 2 × 2 ANOVA on the RTs showed no significant main effect for group or condition (congruent, incongruent), respectively \[group: *F*(1,43) = 0.107, *p* = 0.745; condition: *F*(1,43) = 0.004, *p* = 0.95\], whereas the group × condition interaction was significant \[*F*(1,43) = 8.03, *p* = 0.007\]. Moreover, RTs in different conditions were significantly different both for AHAs \[*F*(1,43) = 3.61, *p* = 0.044\] and for HCs \[*F*(1,43) = 4.448, *p* = 0.04\]. Specifically, AHAs tended to have quicker response to targets preceded by drug-related cues compared to targets preceded by neutral images, whereas the opposite pattern was observed in HCs (**Figure [2](#F2){ref-type="fig"}**).

![Reaction time (RT) for abstinent heroin addict (AHA) and healthy control (HC) groups in congruent and incongruent conditions, respectively. The reaction times (RTs) in the congruent condition, as compared to the incongruent condition, was significantly shorter for AHAs (*p* = 0.044) and significantly longer for HCs (*p* = 0.040). Error bars denote standard error. ^∗^*p* \< 0.05.](fnhum-11-00646-g002){#F2}

To investigate the effects of drug-related cues on the allocation of attentional resources, we compared the ERP components between AHAs and HCs. In particular, we investigated the image-elicited P1 (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}), N1, P2, and N2 (**Figure [3](#F3){ref-type="fig"}**), and target-elicited P3 (**Figure [4](#F4){ref-type="fig"}** and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). Using a repeated-measure ANOVA, we observed a main effect of group on P1 latency \[*F*(1,43) = 15.246, *p* \< 0.001\], N1 amplitude \[*F*(1,43) = 4.418, *p* = 0.041\], P2 amplitude \[*F*(1,43) = 5.336, *p* = 0.026\], N2 amplitude \[*F*(1,43) = 19.486, *p* \< 0.001\], and P3 latency \[*F*(1,43) = 25.683, *p* \< 0.001\], but not on P1 amplitude \[*F*(1,43) = 0.423, *p* = 0.519\] or P3 amplitude \[*F*(1,43) = 0.676, *p* = 0.416\]. Condition (congruent vs. incongruent) and group (AHA vs. HC) had a significant interaction effect on P3 amplitude \[*F*(1,43) = 7.140, *p* = 0.011\], but not on P3 latency \[*F*(1,43) = 0.489, *p* = 0.488\]. For P3 amplitude, the congruent or incongruent condition showed a significant effect on P3 amplitude for the AHA group \[*F*(1,43) = 8.08, *p* = 0.007\], but not the HC group \[*F*(1,43) = 0.76, *p* = 0.388\] (**Figure [4C](#F4){ref-type="fig"}**). Importantly, the amplitudes of target-elicited P3 showed significantly positive correlation with RTs in both congruent (*r* = 0.5634, *p* \< 0.01) and incongruent conditions (*r* = 0.5561, *p* \< 0.01) for HCs (**Figure [5A](#F5){ref-type="fig"}**). Surprisingly, anti-correlations were obtained in both congruent condition (*r* = -0.2450, *p* = 0.2844) and incongruent condition (*r* = -0.1303, *p* = 0.5734) for AHAs, although they did not reach significance (**Figure [5B](#F5){ref-type="fig"}**). Notably, we did not find any significant correlation between RT and withdrawal time (*r* = -0.063, *p* = 0.787 for congruent condition; *r* = 0.117, *p* = 0.612 for incongruent condition), neither between P3 amplitude and withdrawal time (*r* = -0.040, *p* = 0.865 for congruent condition; *r* = -0.132, *p* = 0.570 incongruent condition).

![Event-related potential (ERP) analysis for the image-related responses. **(A)** The grand average ERP waveforms for the image-related responses from the selected electrode for the drug cues in the left (Left), drug cues in the right (Middle), and the averaged across left and right cases (Right). The N1 and P2 ERPs for the drug cues presented in the left are from the O2 electrode, whereas the ERPs for the drug clues in the right are from the O1 electrode. The N2 waveforms are extracted from the FCz electrode. The time windows for N1, P2, and N2 are marked by the gray shadow, where were 170--220 ms, 240--320 ms, and 250--350 ms, respectively. The red and blue lines refer to AHA and HC group, respectively. **(B)** Scalp topography of the N1 (Left), P2 (Middle), and N2 (Right) components for left and right drug cues, for AHA and HC groups, respectively. The components are averaged across subjects and time windows. **(C)** Bar plots show mean and standard error of the intensity of N1 (Left), P2 (Middle), and N2 (Right) components for AHA group (red) and HC group (blue), respectively. Error bars denote standard error. ^∗^*p* \< 0.05.](fnhum-11-00646-g003){#F3}

![P3 component for the target-related responses. **(A)** The grand average ERP waveform in congruent (Left) and incongruent condition (Right). The P3 time window is marked by a gray shadow. The AHA group is depicted in red, and the HC group in blue. **(B)** Scalp topography of P3 component per group per condition. The P3 component is averaged across subjects and time windows. **(C)** Bar plots for P3 latency (Left) and amplitude (Right) per group per condition. Error bars denote standard error. ^∗^*p* \< 0.05.](fnhum-11-00646-g004){#F4}

![Relationship between P3 amplitude and RT. The P3 amplitude is significantly correlated with RT in both congruent and incongruent conditions for HCs **(A)**. In contrast, it was anticorrelated with RT for AHAs **(B)**. Three HCs (marked with a gray shadowed circle) were excluded from the analysis as they were considered outliers.](fnhum-11-00646-g005){#F5}

Source localization revealed several brain regions for image-related ERP components (i.e., P1, N1, P2, N2) of interest (**Figure [6](#F6){ref-type="fig"}**, **Table [1](#T1){ref-type="table"}**, and Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). During the P1 time window, dorsal posterior cingulate cortex (dPCC) and superior parietal lobe (SPL) were significantly more active in AHAs than in HCs, whether the drug-related cue was presented in the left or right hemi-spatial field. Also, strong neuronal activity in dPCC in AHAs was maintained until the N1 response. For the P2 and N2 time windows, we found significant clusters of differential activation in the SPL and IFG for drug-related cue both in the left or right hemi-spatial fields. We then examined the neural sources associated with target-related P3 activity (**Figure [7](#F7){ref-type="fig"}**, **Table [1](#T1){ref-type="table"}**, and Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). We observed the medial parietal lobe and occipital lobe in AHAs to be significantly less active both in congruent and incongruent conditions, whereas brain activity in MTG was reduced for AHAs in the incongruent condition, but not the congruent condition. A within-subject comparison showed reduced activity in superior frontal gyrus (SFG), dorsolateral prefrontal lobe, dorsal anterior cingulate cortex (dACC) and IPL for AHAs in the incongruent compared to the congruent condition, whereas no brain regions showed differential activity between two conditions for HCs.

![Between-subject comparisons for image-elicited ERP sources. The *t*-score maps for the comparison between AHAs and HCs for P1 component **(A)**, N1 component **(B)**, and P2 and N2 component **(C)** are shown for drug-related cues presented in the left and right visual fields, respectively. The brain regions with yellow/red color indicate AHAs \> HCs, whereas green/blue color indicates AHAs \< HCs. The time periods for different components are indicated as well. To be noticed, the time window for P2 and N2 components are overlapping. Significant brain regions (*p* \< 0.05, FWE corrected) were indicated on the map. The peak MNI coordinate regions for each comparison are reported in **Table 1**. dPCC, dorsal posterior cingulate cortex; IFG, inferior frontal gyrus; SPL, superior parietal lobule.](fnhum-11-00646-g006){#F6}

###### 

Peak MNI coordinates for between-subject factor comparison of between abstinent heroin addicts (AHAs) and healthy controls (HCs).

  Component   Time (ms)   Condition   Coordinate region   Peak MNI coordinate   *P*-value        
  ----------- ----------- ----------- ------------------- --------------------- ----------- ---- -----------
  P1          90--160     LEFT        dPCC                0                     -57         26   0.0256^∗^
                                      SPL                 0                     -57         30   
                          RIGHT       dPCC                5                     -52         35   0.0172^∗^
                                      SPL                 0                     -57         30   
  N1          150--220    LEFT        dPCC                10                    -52         30   0.0446^∗^
                          RIGHT       dPCC                -15                   -57         30   0.0386^∗^
  P2\| N2     260--350    LEFT        SPL                 40                    -61         49   0.0396^∗^
                          RIGHT       IPFG                -30                   19          -5   0.0438^∗^
  P3          380--550    CON         OL                  -5                    -80         25   0.0132^∗^
                                      MPL                 -5                    -75         25   
                          INCON       MOL                 0                     -100        -5   0.0264^∗^
                                      OL                  -5                    -100        0    
                                      MTG                 -65                   -50         0    

Clusters surviving threshold of p \< 0.05 family-wise error (FWE)-corrected. Abbreviations: dPCC, dorsal posterior cingulate cortex; IPFG, inferior prefrontal gyrus; MPL: medial parietal lobe; MOL: medial occipital lobe; OL: occipital lobe; MTG: middle temporal gyrus; SPL, superior parietal lobule; CON: congruent; INCON: incongruent.

∗

p \< 0.05.

![P3 Source analysis. **(A)** The *t*-score maps for the comparison between AHAs and HCs are shown in the congruent (Up) and incongruent condition (Bottom), respectively. The brain regions with green/blue color indicate AHAs \< HCs. The significant differences between brain regions \[*p* \< 0.05, family-wise error (FWE) corrected\] were indicated in the map. The peak MNI coordinates for the contrast between groups are reported in **Table [1](#T1){ref-type="table"}**. **(B)** *T*-score maps for the comparison between congruent and incongruent conditions for AHA group (Up) and HC group (Bottom), respectively. The brain regions with red color indicate CON \> INCON, whereas those with blue color indicate CON \< INCON. The peak MNI coordinates for the contrast between conditions are reported in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. dACC, dorsal anterior cingulate cortex; dlPFL, dorsal-lateral prefrontal lobe; IPL, inferior parietal lobe; MOL, medial occipital lobe; MPL, medial parietal lobe; MTG, middle temporal gyrus; OL, occipital lobe; SFG, superior frontal gyrus; CON, congruent; INCON, incongruent.](fnhum-11-00646-g007){#F7}

Discussion
==========

The present study explored the neural correlates of drug-related AB in AHAs by examining ERP components in a dot-probe task. Our behavioral results confirmed the hypothesis that AHAs respond faster than HCs to dots that replace drug-related stimuli, as compared to neutral stimuli. More importantly, the influence of the drug-related cue on attentional processing was reflected by altered neural responses in the early (sensory) stage, as indexed by the P1, N1, P2 responses, but also the late (cognitive) processing stage, as indexed by the N2 and P3 responses. These findings provided novel insights into the neural mechanisms underlying AB toward the drug-related cues in AHAs.

In line with a previous study ([@B9]), we found behavioral evidence of an AB to drug in the AHA group using the traditional RT measure of drug-related bias in a dot-probe task (i.e., the difference in RT on congruent and incongruent trials). Specifically, we observed faster RTs in congruent as compared to incongruent conditions in AHAs, suggesting that the attention of heroin addicts was attracted by drug-related images even after a certain withdrawal period (**Figure [2](#F2){ref-type="fig"}**). Previous studies showed that drug-related cues could produce a strong subjective craving in AHAs, which may result in AB ([@B22]; [@B51]). On the contrary, HCs showed longer RTs in the congruent compared to the incongruent condition, which might be due to an intrinsic avoidance response to drugs ([@B1]).

The ERP analysis permitted to identify distinct neural responses associated with drug-related AB in AHAs. Visual information processing may be characterized by four different ERP components, related to sensory encoding (around about 80 ms), early categorization (around about 100 ms), and stimulus recognition (around about 150 ms) ([@B76]; [@B48]; [@B68]), and spatial orienting and visual short-term memory (VSTM) ([@B64]; [@B43]) (around about 250 ms). We observed a significantly smaller P1 latency in AHAs than HCs, suggesting that the manifestation of AB started from an early stage of stimulus categorization and drug contexts might be encoded more quickly in AHAs (Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}). However, we did not find significant differences in the contralateral P1 amplitude between AHAs and HCs. This result might be explained by the presence of drug-related image and neutral scenery image bilaterally. Moreover, the source localization for P1 mainly identified dPCC and SPL (**Figure [6](#F6){ref-type="fig"}**). This is in good agreement with other studies showing that dPCC is associated with stimulus encoding ([@B85]), and SPL is involved in maintaining a spatial reference system for goal oriented behavior. It may be associated with spatial integration of visual features ([@B93]; [@B11]; [@B61]) and be also related to attentional shifting ([@B62]; [@B87]). More generally, it is involved in the compilation of an attentional priority map ([@B30]). Unlike the P1 amplitude reflecting the inhibition, the N1 amplitude reflects the amount of initial input to attentional resources to the cues ([@B47]). Our study showed significantly larger N1 amplitude in AHAs than in HCs, especially at parietal and occipital electrodes (**Figures [3A,B](#F3){ref-type="fig"}**). Visual spatial attention signals from parietal to occipital cortex enable top-down attention processing ([@B44]). Accordingly, more attention may be allocated to drug-related cues in AHAs in bottom-up attention process. In line with previous studies ([@B78]), we found the N1 topography to be characterized by a typical bilateral posterior negativity, which is consistent with sources located in bilateral occipital--temporal regions (**Figure [3B](#F3){ref-type="fig"}**, left panel). More specifically, we found dPCC to be hyperactive in AHAs in the N1 time window (**Figure [6B](#F6){ref-type="fig"}**). dPCC is functionally connected with dorsal attention regions ([@B5]) and involved in memory loading for the stimulus processing ([@B68]) and selective processing of external task-relevant information ([@B5]).

The parieto--occipital P2, which was evoked at the latency of around 280 ms by image cues, has been considered to be related to memory performance ([@B17]) and working memory ([@B46]). In turn, N2 is typically associated with response to previous memorized stimuli ([@B34]) and cognitive control of response inhibition. Its neural sources are most likely located in dACC ([@B63]; [@B3]). In line with previous studies ([@B33]; [@B73]; [@B27]), we observed larger P2 amplitude and N2 amplitude in AHAs, possibly indicating the reinforcement of the memory related to drugs and an increased allocation of attention to drug-related stimulus in AHAs. Source localization for P2 and N2 period mainly identified SPL and IFG (**Figure [6C](#F6){ref-type="fig"}**). IFG, a region involved in ventral attention network, is thought to play an important role in stimulus-driven orientation of covert visual spatial attention ([@B10]; [@B80]). Concurring with previous studies ([@B54]), stronger activity in SPL and IFG areas of AHAs during N2 and P2 periods might relate to filtering of irrelevant stimuli.

The analysis of ERPs following the presentation of dot stimuli permitted to investigate how drug-related attention bias affected cognitive processing ([@B21]; [@B50]). Previous studies considered the P3 as an endogenous psychological component, a sign of processes of memory access evoked by evaluation of stimuli in tasks requiring a covert or an overt response ([@B15], [@B16]; [@B74]). In particular, the latency of P3 is associated with the evaluation of stimuli and strategy adjustment for subsequent processing steps ([@B15], [@B16]). Our results showed shorter P3 latency in AHA compared to HC (**Figures [4A,C](#F4){ref-type="fig"}** left panel), reflecting a shorter time required for the evaluation or classification of the stimulus in AHAs, and lower P3 amplitude in AHAs in the congruent compared to the incongruent (**Figures [4C](#F4){ref-type="fig"}** right panel, **[5B](#F5){ref-type="fig"}**). This suggests that working memory in AHAs is slowly updated in the congruent condition ([@B15], [@B16]). P3 amplitudes were found to be positively correlated with RTs (**Figure [5A](#F5){ref-type="fig"}**) for HCs, which is well in line with the concept that larger P3 amplitude reflects greater perceptual load ([@B94]; [@B89]) and higher distribution of psychological resources ([@B74]). This positive correlation was lost in AHAs (**Figure [5B](#F5){ref-type="fig"}**). This might be caused by altered attention processes in AHAs ([@B89]). Previous EEG studies showed that the neurophysiological activity of P3 wave emerge from bilateral occipital areas during visual attention and visual memory cognitive tasks ([@B12]), and fMRI studies indicated that the medial wall of the SPL may contribute to bottom-up visual integration ([@B72]). Concurring with previous studies, our P3 results suggested that the drug-related AB in AHAs might largely affect bottom-up attention processes and memory cognitive responses relevant to the dot stimulus. Importantly, the effects of withdrawal treatment on the bottom-up attention processes (indexed by P3 amplitude or by RT) might not be simply dependent on the withdrawal time, since neither RT nor P3 amplitude was correlated with withdrawal time. Notably, significant differences in the SFG, dorsal-lateral prefrontal cortex (dlFPC), dACC, and IPL were found between the congruent and incongruent conditions in AHAs, but not in HCs (**Figure [7](#F7){ref-type="fig"}**). This indicates differences in AHAs between congruent and incongruent conditions. Previous fMRI studies showed that the response inhibition process in heroin addiction is associated with abnormal brain activity in dACC and SFG ([@B45]; [@B25]; [@B79]). dlPFC is known to be involved in the generation of the P3 component, which reflects top-down processes as stimulus categorization and voluntary decision-making ([@B2]; [@B43]). These results may help explaining why AHAs easily relapse again.

Although our study led to a series of findings that might contribute to a better understanding of attention bias in heroin dependence, some limitations need to be noted. First, the low educational level of subjects, in particular for AHAs, might have an impact on their performance in the task. Second, for the experiment protocol, we did not use a varying time for image presentation, neither a jittered intertrial interval. This may raise questions regarding the extent to which neural and behavioral effects that are attributed to attention are confounded by perceptual expectations. Third, we did not track eye-movements during the experiment. Eye-tracking technology, a non-invasive method for measuring gaze, has been proven to be a useful tool to investigate the visual AB ([@B81]; [@B28]; [@B19]), which can be considered in future studies. Fourth, the low-density EEG montage and the use of a volume conduction template might have limited the spatial resolution and the accuracy of source reconstruction ([@B49]). Finally, we found that early visual stimulus processing affects subsequent cognitive processing, as measured by RT. Future studies are therefore warranted to disentangle effects of attention and prediction on early stimulus processing.

Conclusion
==========

In this study, we investigated the neural correlates of drug-related attention bias in AHAs. We revealed that primary differences compared to healthy individuals are already coded in early stimulus encoding and recognition. Moreover, late responses were also aberrant, and possibly related to impaired stimulus evaluation and inhibition. Together, these findings may contribute to a better understanding of the neural basis of attention bias.
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